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A novel polypeptide inhibitor, AI-3688, which acts upon human pancreatic a-amylase, was isolated from 
fermentation broth of Streptomyces aureojbciens. The purified peptide contains no unusual amino acids. 
Its M, is 3936. The primary structure of AI-3688 was elucidated by automatic Edman degradation of the 
native or modified Inhibitor. Two intramolecular cysteines form a disulphide bridge, thus creating a ring 
structure consisting of 17 amino acids. Strong sequence homology also exists to another microbrai a-amylase 
inhibitor, tendamistat (HOE 467). This paper discusses the role of a common partial sequence, -Gln-Ser- 
Trp-Arg-Tyr-, present in the loop of both inhibitors as the active site of microbiai peptide ct-amylase inhibi- 
tors. 
cc-Amylase Microbial peptide Amino ucid sequence Primary structure 
1. INTRODUCTION 
Numerous microbial a-glucosidase-inhibiting 
substances of rather diversified chemical structure 
have been described [1,2]. A unique class is peptide 
inhibitors. Compounds of this type act specifically 
upon a-amylases ]3-71. Apparently they are not 
substrate analogues; however, their distinct mode 
of action is as yet unknown. A new peptide (Y- 
amylase inhibitor, AI-3688, has now been isolated 
from Streptomyces aureofaciens, FH 1656, DSM 
2790 [8]. Elucidation of its primary structure 
should help to identify the effective partial se- 
quence of the peptide inhibitors. 
2. MATERIAL AND METHODS 
2.1. ~er~entfftion of AI-3688 
A spore suspension of S. aureofaciens FH 1656, 
DSM 2790 strain was inoculated into 300 ml of a 
seed medium consisting of 4% dextrin, 1% glucose, 
1% casein peptone, 0.4% corn steep liquor, 0.5% 
soybean meal, 0.8% (NH&HPO4, pH 8.3, and in- 
cubated at 28°C for 24 h, 300 ml of the seed 
culture were added to 9 1 of a production medium 
as above using a 12-1 jar fermentor. Fermentation 
was carried out at 28°C under aeration of 420 l/h 
and agitation at 850 rpm. tu-Amylase inhibitor pro- 
duction began 20 h after inoculation, then, gradu- 
ally increasing, reached a maximum of 60 mg/l 
after 96 h. 
2.2. Purification procedure 
The fermentation broth (8 I) was centrifuged and 
the supernatant was adjusted to pH 4.9 and ab- 
sorbed on a column (0.4 1) of resin Diaion HP-20. 
The column was washed with water and then with 
mixtures of water and isopropanol. The inhibitor 
was eluted with 25% isopropanol. Active fractions 
were collected and isopropanol was removed under 
reduced pressure. After concentration by ultrafil- 
tration, the enriched solution was applied onto a 
DEAE-Sephadex column, equilibrated with phos- 
phate buffer, pH 7.4. The inhibitor was eluted 
with 0.4 M NaCl using an NaCI gradient of O-O.5 
M. The fractions containing AI-3688 were again 
concentrated and desalted by ultrafiltration. Final 
purification was performed by chromatography on 
Sephadex G-50 fine using 30 mM phosphate buf- 
fer. a-AmyIase inhibitor AI-3688 had a purity of 
99% as indicated by gel electrophoresis. 
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2.3. Characterization of AZ-3688 
Analytical disc gel electrophoresis [9], deter- 
mination of the isoelectric point and the formation 
of the complex with a-amylase (porcine pancreas) 
were performed as in [4]. The a-amylase-inhibiting 
activity was determined as described in [lo]. 
2.4. Reduction with dithioerythritol 
10 mg Lu-amylase inhibitor AI-3688 were dis- 
solved in 5 ml of 8 M urea, mixed with 10 mg 
dithioerythritol in a closed vessel and allowed to 
stand for 24 h at room temperature. Samples were 
removed after 1, 2, 3 and 24 h and enzymatically 
examined. 
2.5. Oxidation with performic acid [IlJ 
5 ml performic acid were made by allowing 4.5 
ml formic acid to react with 0.5 ml hydrogen 
peroxide (30%) for 30 min at room temperature. 
20 mg AI-3688 were dissolved in 1 ml formic acid 
and oxidized for 3 h at 0°C with 2.5 ml performic 
acid. The sample was then diluted with water and 
evaporated to remove the formic acid. This step 
was repeated several times. Finally, the sample was 
lyophilized. 
2.6. Amino acid analysis and sequence 
determination 
Amino acid analysis was performed according to 
Spackman et al. [12]. Automatic Edman degrada- 
tion in liquid phase with 1 mg Polybren and 0.1 M 
Quadrol was performed in a Beckman 890C se- 
quencer equipped with a cold trap [ 13,141. After 
drying, released amino acid thiazolinone was 
manually converted to phenylthiohydantoin with 
1 N HCl and 0.01% thioethanol at 80°C for 10 
min, dried and identified using HPLC on a Shan- 
don Hypersil C-18 column with sodium acetate 
buffer (pH 5.3) and acetonitrile as organic modi- 
fier. Quantification was performed using N- 
leucine as internal standard. 
3. RESULTS 
3.1. Purification and chemical composition of 
AZ-3688 
During a screening program to obtain new kinds 
of microbial Ly-amylase inhibitors, the new produc- 
ing strain S. aureofaciens FH1656 was found. 
Submerged, aerobic culturing of the strain using a 
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culture medium containing starch resulted in the 
formation of the cu-amylase inhibitor AI-3688. The 
method of isolation described above yielded a gel 
electrophoretically homogeneous material. Amino 
acid analysis revealed the AI-3688 to be composed 
solely of the natural amino acids; Lys, Met, His, 
Leu and Ile are absent. The isoelectric point is 4.2, 
the UV absorption corresponds to the protein spec- 
tra: A,,, = 276 nm (A{?,,, = 21). The inhibitor is 
freely soluble in water and stable between pH 2-10 
at room temperature. 
3.2. Biochemical properties 
In the photometric enzyme test, AI-3688 inhibits 
the a-amylase from porcine pancreas. The specific 
inhibitory action was determined to be 1.5 x 10’ 
IU/mg. The effect of the inhibitor is 5-times lower 
against human salivary amylase in comparison to 
the pancreatic a-amylase, and almost ineffective 
against the cu-amylase from Bacillus subtilus. 
Maximal inhibition against the pancreatic CY- 
amylase is attained after 5 min preincubation of 
the enzyme with AI-3688; inhibition is independent 
of the pH. 
Mixtures of the pancreatic amylase with the in- 
hibitor produce a complex which can be clearly 
recognized by gel electrophoresis. If the ratio of in- 
hibitor to enzyme is increased to 12 : 1, none of the 
original components are detectable; a stoichio- 
metric ratio of 1 : 1 exists. 
Complex formation and cu-amylase inhibition 
proceed unchanged even in the presence of lOO- 
times the molar amount of p-chloromercuriben- 
zoate [ 151. Free -SH groups evidently play no part 
in the mechanism of a-amylase inhibition. On the 
other hand, the intact disulphide bridge of the in- 
hibitor is necessary for its efficacy. Reduction of 
the bridge in 8 M urea solution leads to a time- 
dependent inactivation of AI-3688. After 1, 2, 3 
and 24 h, 85, 75, 66 and 2%, respectively, of the 
implemented inhibitory efficacy are recovered. 
3.3. The primary structure of the inhibitor 
AZ-3688 
Automatic Edman degradation of the native in- 
hibitor and of the S-oxidized form was performed 
to determine the amino acid sequence (table 1). 
AI-3688 consists of 36 amino acids, arranged 
linearly, the 2 cysteines of the molecule creating a 
ring closure of the chain by formation of a disul- 
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Table 1 
Sequence analysis of AI-3688 
Step Amino acid Yield 
identified (nmol) 
1 Ala 3.45 
2 Thr 2.3 
3 GlY 1.78 
4 Serb 
5 Pro 3.1 
6 Ala 2.7 
7 Pro 2.5 
8 Asp 1.75 
9 cysa 
10 Val 2.0 
11 Glu 1.6 
12 Serb 
13 Phe 1.2 
14 Ciln 1.4 
15 Serb - 
16 Trp 0.38 
17 Ar8 0.98 
18 Tyr 1.08 
19 Thr 0.68 
20 Asp 1.0 
21 Val 0.86 
22 Ar8 0.68 
23 Asn 1.05 
24 GlY 0.41 
25 cysa - 
26 Serb - 
27 Asp 0.56 
28 Ala 0.53 
29 Val 0.53 
30 Thrb 
31 Val 0.51 
32 Val 0.6 
33 Val 0.66 
34 Gin 0.31 
35 Tyr 0.30 
36 Glu 0.33 
a Identified as cysteic acid from oxidized material 
b Identified as -Ser and as -Thr by the monitoring at 320 
nm 
phide bridge. Fig.1 shows the primary structure. 
Among the proteins described to date, the amino 
acid sequence discovered is similar only to that of 
the microbial a-amylase inhibitor tendamistat 
(HOE-467). Sequence homology is more than 55%. 
4. DISCUSSION 
The mode of action of microbial proteins in- 
hibiting a-amylase is not yet known. In particular, 
parts of these proteins responsible for their ef- 
ficacy have not been discovered. The newly found 
inhibitor AI-3688 possesses very similar enzyme- 
inhibiting characteristics to tendamistat: (i) pan- 
creatic cu-amylase is inhibited, (ii) inhibition is in- 
dependent of pH, (iii) a 1: 1 inhibitor/enzyme 
complex is formed and (iv) the presence of the in- 
tact ring is necessary for inhibitory efficacy. 
A comparison of the 2 primary structures reveals 
significant sequence homology from amino acid 3 
to 39 of tendamistat, including the position and 
size of the ring. An alignment of the sequences is 
given in fig. 1. Consequently, the inhibitorily effec- 
tive part of HOE 467 seems to be associated with 
the 17-linked ring of the molecule or its environ- 
ment. A Chou and Fasman calculation [ 161 to 
determine the chain formation shows that within 
the loops of AI-3688 and tendamistat respectively, 
the sequence -Gin-Ser-Trp-Arg-Tyr- is spatially ex- 
posed. In both molecules, the bridge-forming 
disulphides bend and stabilize the amino acid 
chains in such a way that this Gln-Ser-Trp-Arg- 
Tyr- sequence can become exposed. However, in 
AI-3688 this sequence is located at the end of an LY- 
helix, while in HOE 467 it is in a longer P-sheet 
structure. These data suggest hat the partial se- 
quence -Gin-Ser-Trp-Arg-Tyr- may correspond to 
the active site of the microbial protein-type LY- 
amylase inhibitors. 
189 
Volume 185, number I FEBS LETTERS 
1 
AI-3688 (1) H2N - Ala - Thr - Gly - Ser 
Tendamistat (2) H2N - Asp - Thr - T+i - Val - Ser - Glu f 
June 1985 
- Ser - Asp - Ala 
- Ala - Glu - Thr 
Fig.1. The amino acid sequence of AI-3688 and comparison with the primary structure of tendamistat (HOE 467). A 
disulphide bridge exists between the Cys (9) and Cys (25) of AI-3688 and between Cys (11) and Cys (27) of tendamistat. 
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